Prostate biopsy strategies. A review of the literature;Estrategias para la biopsia de próstata. Revisión de la literatura

Actas Urologicas Espanolas

Volumn 31, Issue 10, 2007, Pages 1089-1099

  Ramirez Backhaus M ^a   Trassierra Villa, M ^a   Arlandis Guzman S ^a   Delgado Oliva, F ^a   Boronat Tormo, F ^a   Jimenez Cruz J F ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Biopsy; Prostate; Prostate cancer

Indexed keywords

BIOPSY; HUMAN; MALE; METHODOLOGY; PATHOLOGY; PROSTATE; PROSTATE TUMOR; REVIEW;

BIOPSY; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS;

EID: 44449087017     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-4806(07)73770-1     Document Type: Review

References (92)

1. Terris MK. Prostate biopsy strategies: past, present, and future. Urol Clin N Am. 2002;29(1):205-212.
2. Schlegel JU, Diggdon P, Cuellar J. The use of ultrasound for localizang renal calculi. J. Urol. 1961;86:367-369.
3. Watanabe H, Kato H, Kato T, Morita M, Tanaka M. Diagnostic aplication of the ultrasoundotomography for the prostate. Nippon Hinyokika Gakkai Zasslid. 1968;59 (4):273-279.
4. Lee F, Gray JM, McLeary RD, Meadows TR, Kumasaka GH, Borlaza GS, et al. Transrectal ultrasound in the diagnosis of prostate cancer: location, echogenicity, histopathology, and staging. Prostate. 1985;7(2):117-129.
5. Radge H, Aldape HC, Bagley CM Jr. Ultrasound guided prostate biopsy: biopsy gun superior to aspiration. Urology. 1988;32(6):503-506.
6. Lee F, Torp-Pedersen ST, Siders DB. The role of transrectal ultrasound in the early detection of prostate cancer. CA Cancer J Clin. 1989;39(6):337-360.
7. Hodge KK, Macneal JE, Stamey TA. Ultrasound guided transrectal core biopsy of the palpably abnormal prostate. J Urol. 1989;142(1):66-70.
8. Carter HB, Hamper UM, Sheth S, Sanders RC, Epstein JI, Walsh PC. Evaluation of ultrasound in the early detection of prostate cancer. J Urol. 1989;142(4):1008-1010.
9. Ellis WJ, Chetner MP, Preston SD, Brawer MK. Diagnosis of prostatic carcinoma: The yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. J Uro 1994 Nov; 152[5 Pt 1] 1520-1525.
10. Hammerer PG. Sonographic diagnosis of prostatic cancer. Radiologe. 1994;34(3):116-121.
11. Hammerer PG, Huland H. Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol. 1994;151(1):99-102.
12. Rodríguez-Patrón Rodriguez R, Mayayo Dehesa T, Burgos Revilla FJ, Alonso González M, Lennie Zucharino A, García González R. Resultados de una serie de 6000 pacientes con biopsia transrectal ecodirigida de próstata. Parte I; Anatomía Patológica, Tacto rectal, Ecografía transrectal y PSA. Arch Esp Urol. 2005;58(7):623-634.
13. Pelzer A, Bektic J, Berger AP, Pallwein L, Halpern EJ, Horninger W, Bartsch G, Frauscher F. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol. 2005;173(6):1926-1929.
14. Frauscher F, Pallwein L, Klauser A, Berger AP, Koppelstaetter F, Gradl J et al. Ultrasound contrast agents and prostate cancer Radiologe. 2005;45(6):544-551.
15. Mehta SS, Azzouzi AR, Hamdy FC. Three dimensional ultrasound and prostate cancer. World J Urol. 2004;22(5): 339-345.
16. Ito H, Kamoi K, Yokoyama K, Yamada K, Nishimura T. Visualization of prostate cancer using dynamic contrast-enhanced MRI: comparison with transrectal power Doppler ultrasound. Br J Radiol. 2003;76(909):617-624.
17. Yuen JS. Re Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol. 2003; 170(1):192-193.
18. Carter B, Partin AW. Urology Campbell 8Ed 816-817.
19. Vallancien G, Prapotnich D, Veillon B. et al. Systemic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol. 1991;146(5):1308-1312.
20. Brown RW, Warner JJ. Turner BI et al. Bacteremia and bacteriuria after transrectal prostatic biopsy. Urology. 1981;18(2):145-148.
21. Lindert KA, Kabalin JN, Terris MK. Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol. 2000;164(1):76-80.
22. Carey JM, Korman HJ. Transrectal ultrasound guided biopsy of the prostate. do enemas decrease clinically significant complications? J Urol. 2001;166(1):82-85.
23. Davis M, Sofer M, Kim SS, Soloway MS. The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. J Urol. 2002;167(2Pt 1):566-570.
24. Clements R, Aideyan OU, Griffiths GJ Peeling WB. Side effects and patient acceptability of transrectal biopsy of the prostate. Clin Radiol. 1993;47(2):125-126.
25. Collins GN, Lloyd SN, Hehir M, McKelvie GB. Multiple transrectal ultrasound-guided prostatic biopsies true morbidity and patient acceptance. Br J Urol. 1993;71(4):460-463.
26. Nash PA, Bruce JE, Indudhara R, Shinohara K. Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate. J Urol. 1996;155 (2):607-609.
27. Soloway M, Obek C. Periprostatic local anesthesia before ultrasound guided prostate biopsy. J Urol. 2000;163(1): 172-173.
28. Wu CL, Carter BH. Naqibudin M et al. Effect of local anesthesics on patient recovery after transrectal biopsy. Urology 2001;57(5):925-959.
29. Taverna G, Maffezini M, Benetti A, Seveso M, Giusti G, Graziotti P. A single injection of lidocame as local anaesthesia for ultrasound guided biopsy of the prostate. J Urol. 2002;167(1):222-223.
30. Seymour H, Perry MJA, Lee-Elliot C. Pain after transrectal ultrasonographi-guided biopsy. The adventages of periprostatic local anaesthesia. BJU hit. 2001;88(6):540-544.
31. Issa MM, Bux S, Chun T, Petros JA, Labadia AJ, Anastasia K et al. A randomized prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy: the Emory University experience. J Urol. 2000;164(2):397-399.
32. Alavi AS, Soloway MS, Vaidya A, Lynne CM, Gheiler EL. Local anesthesia for ultrasound guided prostate biopsy: a prospective randomized trial comparing 2 methods. J Urol. 2001;166:1343-1345.
33. Massod J, Shah N, Lane T. Nitrous Oxide (entonox) inhalation and tolerance of transrectal ultrasound guided prostate biopsy: a double-blind randomised controlled study. J Urol. 2002;168(1):116-120.
34. Peters JL, Thompson AC, Mcnicholas TA et al. Increased patient satisfaction form transrectal ultrasound-guided biopsy under sedation BJU Int. 2001;87(9):827-830.
35. Moinzadeh A, Mourtzinos A, Triaca V. A randomised double blind prospective study evaluating patient tolerance of transrectal ultrasound-guided biopsy of the prostate using prebiopsy rofecoxib. Urology 2003;62(6):1054-1057.
36. Haq A, Patel HRH, Habib Mr. Diclofenac suppository analgesia for transrectal ultrasound guided biopsy of the prostate: a double blind, rendomized controlled trial. J Urol. 2004;171(4):1489-1491.
37. Bastide C, Lechevallier E, Egbazarian C, Ortega JC, Coulange C. Tolerance of pain during transrectal ultrasound-guided biosy of the prostate: risk factors. Prostate Cancer Prostatic Dis. 2003;6(3):239-241.
38. Griffith BC, Morey AF, Ali-Khan MM, Canby-Hagino E, Foley JP, Rozanski TA. Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol. 2002; 1680:1021-1023.
39. Bonillo MA, Bosquet M, Arlandis S, Trassierra M, Ramírez M, Jiménez JF. Profilaxis antibiótica en la biopsia de prostate. C-59 LXX Congreso Nacional de Urología Jun 2005.
40. Sieber PR, Rommel FM, Agusta VE. Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol. 1997;157(6):2199-2200.
41. Aus G, Ahlgren G, Bergdahl S. Infection after transrectal core biopsies of the prostate: risk factors and antibiotic prophylaxis. Br J Urol. 1996;77(6):851-855.
42. Norberg M, Holmberg L, Haggman M. Determinants of complications after multiple transrectal core biopsies of the prostate. Eur Radiol. 1996;6(4):457-459.
43. Stamey TA. Making the most out of six systematic sextant biopsies. Urology 1995;45(1):2-12.
44. Presti JC Jr, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol. 2003;163(1):163-166.
45. Babaian RJ, Toi A, Kamoi K, Troncoso P, Sweet J, Evans R et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol. 2000; 163(1):152-157.
46. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol. 1997;157(1):199-202.
47. Levine MA, Ittman M, Melamed J, Lepor H. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol. 1998;159(2):471-475.
48. Stewart CS, Leibovich BC, Weaver AL, Lieber MM. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol. 2001;166(1):86-91.
49. Applewhite JC, Matlaga BR, McCullough DL. Results of the 5 region prostate biopsy method: the repeat biopsy population. J Urol. 2002;168(2):500-503.
50. Singh H, Canto EI. Shariat SF, Kadmon D, Miles BJ, Wheeler TM et al. Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy. J Urol. 2004;171(3):1089-1092.
51. Crawford ED, Shandra S, Wilson SS, Torkko KC, Hirano D, Stewart IS et al. Clinical staging of prostate cancer: a computer-simulated study of transperineal Prostate biopsy. Br Jour Urol. 2005;96(7):999-1004.
52. Furuno T, Demura T, Kaneta T, Gotoda H, Muraoka S, Sato T et al. Difference of cancer core distribution between first and repeat biopsy: in patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy. Prostate 2004;58(1):76-81.
53. Vashi AR, Wojno KJ, Gillespie B, Oesterling JE. A model for the number of cores per prostate biopsy based on patient age and prostate gland volume. J Urol. 1998;159(3):920-924.
54. Schmid H, McNeal JE, Stamey TA. Observations on the doubling time of prostate cancer: the use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer 1993;71(6): 2031-2040.
55. Dugan JA, Bostwick DG, Myers RP, Qian J, Bergstralh EJ, Oesterling JE. The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA. 1996;275(4):288-294.
56. Bostwick DG, Graham SD Jr, Napalkov P, Abrahamsson PA, di Sant'agnese PA, Algabe F et al. Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology. 1993;41(5):403-411.
57. Remzi M, Fong YK, Dobrovits M, Anagnostou T, Seitz C, Waldert M et al. The vienna nomogram: Validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol. 2005; 174(4Pt 1):1256-1261.
58. Bazinet M, Karakiewicz PI, Aprikian AG, Trudel C, Aronson S, Nachabe M et al. Value of systematic transition zone biopsies in the early detection of prostate cancer. J Urol. 1996;155(2):605-606.
59. Epstein JI, Walsh PC, Sauvegeot J, Carter HB. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. J Urol. 1997;158(5):1886-1890.
60. Keetch DW, Catalona WJ. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostatic specific antigen values. J Urol. 1995;154(5):1795-1797.
61. Lui PD, Terris MK, McNeal JE, Stamey TA. Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J Urol. 1995;153(3Pt2):1000-1003.
62. Seaman EK, Sawczuk IS, Fatal M, Olsson CA, Shabsigh R. Transperineal prostate needle biopsy guided by transurethral ultrasound in patients without a rectum. Urology. 1996;47(3):353-355.
63. Shinghal R, Terris MK. Limitations of transperineal ultrasound-guided prostate biopsies. Urology. 1999;54(4):706-708.
64. Taneja SS, Penson DF, Epelbaum A, Handler T, Lepor H. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen. J Urol. 1999;162(4):1352-1357.
65. Sanwick JM, Dalkin BL, Nagle RB. Accuracy of prostate needle biopsy in predicting extracapsular tumor extension at radical retropubic prostatectomy: application in selecting patients for nerve-sparing surgery. Urology. 1998;52:814-818.
66. Ravery V, Boccon-Gibod LA, Dauge-Geffroy MC et al. Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology. 1994;44(3):371-376.
67. Tombal B, Tajeddine N, Cosyns, Feyaerts A, Opsomer R, Wese F et al. Does site-specific labelling and individual processing of sextant biopsies improve the accuracy of prostate biopsy in predicting pathological stage in patients with T1c prostate cancer? Br Jour Urol. 2002;89(6):543-548.
68. Gómez Ferrer A. Análisis computerizado de la imagen computerizada transrectal en el cáncer de próstata localizado. 2004 Tesis Doctoral Univ. Valencia.
69. Aus G, Hermansson CG, Hugosson J, Pedersen KV. Transrectal ultrasound examination of the prostate: complications and acceptance by patients. Br J Urol. 1993;71(4):457-459.
70. Torp-Pedersen S, Lee F, Littrup PJ, Siders DB, Kumasaka GH, Solomon MH et al. Transrectal biopsy of the prostate guided with transrectal US. longitudinal and multiplanar scanning. Radiology 1989;170(1Pt1):23-27.
71. Peyromaure M, Ravery V, Messas A, Toublanc M, Boccon-Gibod L, Boccon-Gibod L. pain and morbidity of an extensive prostate 10- biopsy protocol: a prospective study in 289 patients. J Urol. 2002;167(1):218-221.
72. Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schroder FG. Complication rates and risk factors of 5802 transrectal ultrasound guided sextant biopsies of the prostate within a population based screening program. Urology. 2002;60(5):826-830.
73. Makinen T, Auvinen A, Hakama M, Stenman UH. Tammela TL. Acceptability and complications of prostate biopsy in population-based SA screening versus routine clinical practice: a prospective, controlled study. Urology 2002;60 (5):846-850.
74. Naughton CK, Ornstein DK, Smith DS, Catalona WJ. Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores. J Urol. 2000;163(1):168-171.
75. Ghani KR, Dundas D, Patel U. Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol. BJU Int. 2004;94(7):1014-1020.
76. Kaneko T, Suzuki T, Matsushita N, Yoshida I. Transcatheter arterial embolization for bleeding of prostatic artery after prostate biopsy Nippon Hinyokika Gakkai Zasshi. 2003;94(7):693-695.
77. Brullet E, Guevara MC, Campo R, Falcó J, Puig J, Prera A et al: Massive rectal bleeding following transrectal ultrasound-guided prostate biopsy. Endoscopy. 2000;32(10): 792-796.
78. Enlund AL, Varenhorst E. Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases. Br J Urol. 1997;79(5):777-780.
79. Borboroglu PG, Comer SW, Riffenburgh RH, Amling CL. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol. 2000;163(1):158-162.
80. Lujan Galan M, Paez Borda A, Fernandez Gonzalez I, Romero Cajigal I, Gomez de Vicente JM, Berenguer Sanchez A. Efectos adversos de la biopsia prostática transrectal. Un análisis de 303 procedimientos. Actas Urol Esp. 2001;25(1):46-49.
81. Rodriguez-Patron Rodriguez R, Navas Elorza E, Quereda Rodriguez-Navarro C, Mayayo Dehesa T. Meningitis caused by multiresistant E. coli after an echo-directed transrectal biopsy Actas Urol Esp. 2003;27(4):305-307.
82. Miller J, Perumalla C, Heap G. Complications of transrectal versus transperineal prostate biopsy. ANZ J Surg. 2005;75(1-2):48-50.
83. Bauer JJ, Zeng J, Weir J, Zhane W, Sesterhenn IA, Connelly RR et al. Three-dimensional computer-simulated prostate models: lateral prostate biopsies increase the detection rate of prostate cancer. Urology. 1999;53(5):961-967.
84. Eskicorapci SY, Bayda DE, Akbal C, Sofikerim M, Gunay M, Ekici S et al. An extended 10-core transrectal ultrasonography-guided prostate biopsy protocol improves the detection of prostate cancer. Eur Urol. 2004;45(4):444-448.
85. Beurton D, Barthélémy Y, Fontaine E. Twelve systematic prostate biopsies are superior to sextant biopsies for diagnosing carcinoma: a prospective randomized study. Br J Urol. 1997;80:239-242.
86. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol. 2000;164(2):388-392.
87. Rodríguez-Patrón Rodríguez R, Mayayo Dehesa T, Alonso González M, Burgos Revilla FJ, Garcia González R, Lennie Zucharino A. Rentabilidad de la biopsia de prostate ampliada con 10muestras prostáticas. Estudio prospectivo sobre 222 pacientes. Arch Esp Urol. 2006;59(1):15-24.
88. Torp-Pedersen S, Lee F, Littrup PJ, Siders DB, Kumasaka GH, Solomon MH et al. Transrectal biopsy of the prostate guided with transrectal US. longitudinal and multiplanar scanning. Radiology 1989;170(1Pt1):23-27.
89. Peters JL, Thompson AC, McNicholas TA, Hines JE, Hanbury DC, Boustead GB. Increased patient satisfaction from transrectal ultrasonography and biopsy under sedation. BJU Int. 2001;87(9):827-830.
90. Ramírez M, Trasierra M, Delgado F, Gómez L, Arlandis S, Pontones JL, Jiménez JF. Estudio comparativo entre la biopsia sextante y la ampliada con toma de 10 cilindros. Póster. Reunión Nacional grupo Uro-Oncológico. 2006. Granada.
91. Elabbady AA, Khedr MM. Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of gleason score. Eur Urol. 2006;49(1):49-53.
92. Takenaka A, Hara R, Hyodo Y, Ishimura T, Sakai Y, Fujioka H et al. Transperineal extended biopsy improves the clinically significant prostate cancer detection rate: A comparative study of 6 and 12 biopsy cores. Int J Urol. 2006;13(1):10-14.